Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Elderly patients present management, treatment challenges for cardiologists
-
- Navigating postfellowship burdens with the help of mentors Rahul N. Doshi, MD, FACC, FHRS
- Medicare episode payment models still evolving L. Samuel Wann, MD, MACC, FESC; Erik G. Stilp, MD, FACC
- Combination drug approved for CV prevention in patients at risk for gastric ulcers
- Sugar industry sponsored research to downplay sugar's role in heart disease
- Adults with HIV, depression at elevated risk for MI
- Analysis: PCSK9 inhibitors not cost-effective, could greatly increase US health care costs
- Anemia, iron deficiency common in patients with chronic HF
- Beta-blockers fail to improve outcomes, may raise HF risk after PCI
-
- Cardiac tamponade rates increasing among recipients of permanent pacemakers
- Coronary CTA provides valuable CAD risk stratification in patients with diabetes
- Folic acid-fortified foods associated with reduced risk for congenital heart defects
- Thousands of genes responsible for inherited risk for MI, stroke identified in specific tissues
- Genetic tests may be misdiagnosing hypertrophic cardiomyopathy in black Americans
- Internet, mobile devices can improve healthy lifestyle choices
- Late-onset asthma may increase risk for CV events
- Neurostimulation device shows promise for treatment of central sleep apnea
-
- RESTORE SR: Vanoxerine effective for AF, but harmful in certain patients
- Review: Benefits of statins outweigh harms
- Risk for aortic aneurysm increases with psoriasis severity
- Societies: CAD best diagnosed, managed with myocardial perfusion PET
- Two measures may predict aortic regurgitation, mortality after TAVR
- Women, men undergoing PCI have similar outcomes after short vs. prolonged DAPT
- Hacking vulnerability allegations spawn St. Jude Medical suit, FDA investigation
- BASKET-SAVAGE: DES superior to BMS for revascularization of saphenous vein grafts
-
- Bone marrow stem cells harvested from patient may improve angina
- CLARIFY: Low BP linked with adverse CV outcomes in high-risk patients
- DOCTORS: OCT-guided PCI associated with better outcomes than standard PCI
- ENSURE-AF: Edoxaban noninferior to standard anticoagulation before cardioversion in patients with AF
- ESC position paper addresses cardiotoxicity of cancer therapies
- IV stem cell treatment safe, effective in patients with nonischemic HF
- NORSTENT: DES not superior to BMS for death, MI in patients undergoing PCI
- PRAGUE-18: Prasugrel, ticagrelor confer similar outcomes in patients with STEMI undergoing PCI
-
- SAVE: CPAP does not reduce CV events in patients with CVD, sleep apnea
- Trial Scorecard: ABSORB II
- Trial Scorecard: ATACH-2
- Trial Scorecard: CYRUS
- Trial Scorecard: IPSYS
- Trial Scorecard: OPTICARE
- Trial Scorecard: RESTORE SR
- Trial Scorecard: SAVE
-
- Trial Scorecard: TRIBE-AKI